- gsearch

- gsearch

CDC Stacks Public Health Publications

Search Results

Morbidity and Mortality Weekly Report (MMWR) Morbidity and Mortality Weekly Report (MMWR)

Morbidity and Mortality Weekly Report (MMWR)

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

Narrow Results:
Volume
Series
Publication Year
Medical Subject
Personal Author
  • x
    Shay, David K. (29)
Corporate Author
Place as Subject
Resource Type General
Resource Type Specific
x Shay, David K.
  • Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ACIP 2006
    Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [2006]
    :
    :
    :
  • Prevention and Control of Influenza  Recommendations of the Advisory Committee on Immunization Practices ACIP 2007
    Prevention and Control of Influenza : Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007
    :
    :
    :
  • Prevention and Control of Influenza  Recommendations of the Advisory Committee on Immunization Practices ACIP 2008
    Prevention and Control of Influenza : Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008
    :
    :
    :
  • Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ACIP 2009
    Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
    :
    :
    :
  • Prevention and Control of Influenza with Vaccines  Recommendations of the Advisory Committee on Immunization Practices ACIP 2010
    Prevention and Control of Influenza with Vaccines : Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010
    :
    :
    :
  • Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza  Recommendations of the Advisory Committee on Immunization Practices ACIP
    Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza : Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    :
    :
    :
  • Early Estimates of Seasonal Influenza Vaccine Effectiveness  United States January 2013
    Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013
    :
    :
  • Prevention and Control of Seasonal Influenza with Vaccines  Recommendations of the Advisory Committee on Immunization PracticesUnited States 20132014
    Prevention and Control of Seasonal Influenza with Vaccines : Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014
    :
    :
    :
  • COVID19 Vaccine Safety in Adolescents Aged 1217 Years  United States December 14 2020July 16 2021
    COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
    :
    :
  • Safety Monitoring of an Additional Dose of COVID19 Vaccine  US August 12September 19 2021
    Safety Monitoring of an Additional Dose of COVID-19 Vaccine — U.S. August 12–September 19, 2021
    :
    :
  • Safety Monitoring of the Janssen Johnson  Johnson COVID19 Vaccine  United States MarchApril 2021
    Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
    :
    :
  • Anxietyrelated Adverse Event Clusters After Janssen COVID19 Vaccination  Five US Mass Vaccination Sites April 2021
    Anxiety-related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
    :
    :
  • COVID19 Vaccination and NonCOVID19 Mortality Risk  Seven Integrated Health Care Organizations United States December 14 2020July 31 2021
    COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021
    :
    :
  • AnxietyRelated Adverse Event Clusters After Janssen COVID19 Vaccination  Five US Mass Vaccination Sites April 2021
    Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
    :
    :
  • Vaccine  United States MarchApril 2021
    Vaccine — United States, March–April 2021
    :
    :
  • COVID19 Vaccine Safety in Adolescents Aged 1217 Years  United States December 14 2020July 16 2021
    COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
    :
    :
  • Safety Monitoring of an Additional Dose of COVID19 Vaccine  United States August 12September 19 2021
    Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
    :
    :
  • COVID19 Vaccination and NonCOVID19 Mortality Risk  Seven Integrated Health Care Organizations US December 14 2020July 31 2021
    COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, U.S. December 14, 2020–July 31, 2021
    :
    :
  • COVID19 Vaccine Safety in Children Aged 511 Years  US November 3December 19 2021
    COVID-19 Vaccine Safety in Children Aged 5–11 Years — U.S. November 3–December 19, 2021
    :
    :
  • Cardiac Complications After SARSCoV2 Infection and MRNA COVID19 Vaccination  PCORnet United States January 2021January 2022
    Cardiac Complications After SARS-CoV-2 Infection and MRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022
    :
    :
1 - 20 / 29
Sort By: